Related Experiment Video
Updated: Jan 22, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Nanotechnology based therapeutics for lung disease
Mohammad Doroudian1, Ronan MacLoughlin2,3,4, Fergus Poynton1
1Department of Medicine, Tallaght University Hospital, Dublin 24 & Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.
Nanomedicine offers revolutionary approaches for diagnosing and treating lung diseases, including cancer and COPD. This rapidly growing field integrates various sciences to enhance medical interventions and patient outcomes.
Area of Science:
- Multidisciplinary research integrating chemistry, physics, biology, and materials science.
- Focus on the rapidly growing application of nanomedicine in respiratory medicine.
Background:
- Nanomedicine represents a novel frontier in healthcare.
- Its application to lung diseases is a recent but rapidly expanding area of interdisciplinary science.
Purpose of the Study:
- To review current trends and developments in the clinical translation of nanomedicine for lung diseases.
- To highlight advancements in diagnosis, therapeutic delivery, vaccine development, and medical detection using nanotechnology.
Main Methods:
- Review of current literature on nanomedicine applications in lung diseases.
- Focus on clinical translation and emerging trends.
Main Results:
- Nanomedicine shows significant promise for revolutionizing medical practice.
- Advancements are noted in therapeutic agent delivery, vaccine development, and diagnostic tools for lung conditions.
Conclusions:
- Nano-based approaches are poised to transform the diagnosis and treatment of lung diseases.
- The clinical translation of nanomedicine for conditions like lung cancer, cystic fibrosis, asthma, bacterial infections, and COPD is advancing rapidly.
More Related Videos
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
09:45Generation of 3D Whole Lung Organoids from Induced Pluripotent Stem Cells for Modeling Lung Developmental Biology and Disease
Published on: April 12, 2021
Related Concept Videos
Lung Capacity
Cardiovascular Drugs: Classification based on Therapeutic Indications
Therapeutic Index
Therapeutic Communication
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
Microorganisms in Medicine and Therapeutics
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...